European Molecular Diagnostics Market Growth, Trends and Forecasts (2017 - 2022)

The Europe Molecular Diagnostic Market for the period (2017 - 2022) is expected to account for USD XX billion at a CAGR of XX% from USD XX billion on 2015. Molecular or Nucleic acids based diagnosis of human disorders is referred to as the detections of the various pathogenic mutations in DNA or RNA samples which help us in the process of detection, diagnosis, treatment, prognosis and monitoring response to the therapy.

Molecular diagnostics combines laboratory medicine with the technology and knowledge of molecular genetics and has been enormously revolutionized over the past decades, benefiting from the discoveries in the field of molecular biology. Molecular diagnostics has found a wide application in the detection of infectious and non infectious disease like cancer and has been a major technological revolution for diagnostics in hospital and academic laboratories.

The European Molecular Diagnostic have been driven by a number of factors like increase in the number of infectious and non infectious diseases, technological advancement in microarray, PCR and other technologies, the rapid growth in genomic and proteomic research and the availability of funds specially from the European Commission for molecular diagnostic research. However, the market is restrained by the lack of skilled personnel to handle complex technology, complex regulatory network and government policies and the high cost of the technology.

The European molecular diagnostic market can be segmented based on the technology, products and services, application and end users. Based on technology, the market is segmented into hybridization (ISH, FISH), microarray, DNA sequencing (Capillary electrophoresis, NGS), PCR based methods (cold start PCR, Real time PCR, Reverse Transcriptase PCR, others), Isothermal Nucleic Acid Amplification Technology and Molecular Imaging. Based on products and services, the market is segmented into instruments, reagents, software and services. Based on application, the market is segmented into infectious diseases, cancer, genetic testing, new born screening, blood screening, microbiology and others. Based, on end users the market is segmented as hospitals, academic and research laboratories and others.

Based on geographical location, the Europe molecular diagnostic market can be broadly divided into France, UK, Germany, Spain, Portugal, Scandinavia and Italy.

The current genomic revolution, the fast and accurate quantification at point of care and increase in the number of biomarkers that are in the pipeline research are some of the market opportunities for the key market players. However, they face the challenge of the lack of awareness about the technology among many people and the technology being restricted only to the urban areas of Europe. The key players in the market are Affymetrix, Agilent Technologies, Roche Diagnostics, Bio-Rad Laboratories, Inc, Qiagen N.V. among many others.

Key Deliverables in the Study

Market analysis for the Europe Molecular Diagnostic Market, with region specific assessments and competition analysis on regional scales.

Market definition along with the identification of key drivers and restraints

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market.

Identification and analysis of the macro and micro factors that affect the Europe molecular diagnostic on regional scales

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped


1.1 Study deliveratives

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and forecasr period years

1.6 General Study Assumptions


2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric forecast models

2.4 Research Assumptions




5.1 Current market scenario

5.2 Technology Overview

5.3 New developments in therapeutics

5.4 Investment analysis

5.5 Porters Five Force Analysis

5.5.1 Bargaining Power of suppliers

5.5.2 Bargaining power of buyers

5.5.3 Degree of competition

5.5.4 Threat of substitution

5.5.5 Threat of new entrants


6.1 Market Drivers

6.1.1 Increase in the number of infectious and non infectious diseases

6.1.2 Technological advancement

6.1.3 Growth in genomics and proteomics market

6.1.4 Availabilty of funds for molecular diagnostics from the European Commission

6.2 Market Restraints

6.2.1 Lack of skilled personnels to handle complex technology

6.2.2 Complex regulatory network and government policies

6.2.3 Cost of technolgy is very high

6.3 Market opportunities

6.3.1 Genomic revolution will help grow the market

6.3.2 Fast and accurate quantification at point of care

6.3.3 Increase in the number of biomarkes that are in the pipeline of development

6.4 Key Challenges

6.4.1 Lack of awareness about the technology

6.4.2 Technology restricted to only urban population

7. Europe Molecular Diagnostic market segmentation

7.1 By Technology

7.1.1 Hybridization In-situ Hybridization (ISH) Flourscent In-situ Hybridization (FISH)

7.1.2 Microarray

7.1.3 Mass Spectrometry

7.1.4 DNA Sequencing Capillary Electrophoresis Next Generation Sequencing

7.1.5 Polymerase Chain Raection (PCR) based methods Cold PCR Real time PCR Reverse Transcriptase PCR Quantitative Fluoroscent PCR Others

7.1.6 Isothermal Nucleic Acid Amplification Technology (INAAT)

7.1.7 Molecular Imaging

7.2 By Product and Services

7.2.1 Instruments

7.2.2 Reagents

7.2.3 Software

7.2.4 Sevices

7.3 By application

7.3.1 Infectious diseases

7.3.2 Cancer

7.3.3 Genetic testing

7.3.4 New Born Screening

7.3.5 Blood Screening

7.3.6 Microbiology

7.3.7 Others

7.4 By End users

7.4.1 Hospitals

7.4.2 Academic and Research Laboratories

7.4.3 Others

8. Europe Molecular Diagnostic market by Geography - Regional shares and forecast

8.1 Introduction

8.2 France

8.3 UK

8.4 Germany

8.5 Spain and Portugal

8.6 Scandinavia

8.7 Italy

8.8 Rest of Europe

9. Competitive Landscape

9.1 Merger and Acquisition Analysis

9.2 New Product Launches

9.3 Agreements, Collaborations & Partnerships

10. Company Profiles

10.1 Affymetrix

10.2 Agilent Technologies

10.3 Abbott Laboratories

10.4 Roche Diagnostics

10.5 Qiagen N.V.

10.6 Bio-Rad Laboratories, Inc

10.7 Hologic, Inc

10.8 Grifols

10.9 Siemens Healthcare

10.10 Becton, Dickinson and Company

10.11 Biom?rieux SA

10.12 Cepheid Inc

10.13 Thermo Fisher

11. Analyst Outlook for Investment Opportunities

12. Future Outlook of the Market

Content are not available

Choose License Type